CoagulationDisorders near Clearwater, FL

Care Philosophy: Dr Jennifer Eatrides is a member of the Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. Dr Eatrides earned her MD degree with a research focus at the University of South Florida Morsani College of Medicine. She completed an Internal Medicine Residency and completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center. Dr Eatrides has a particular interest in hematologic malignancies. The MMG faculty at TGH provides invaluable medical oncology services to the large patient population of this leading regional hospital.

Care Philosophy: Dr Bijal Shah is an Associate Member in the Department of Malignant Hematology. Dr Shah's primary clinical interests are in Non-Hodgkin Lymphomas (particularly mantle cell lymphoma) and Acute Lymphoblastic Leukemia. As an internist and pediatrician, Dr Shah also has a special interest in adolescent and young adult malignant hematology.

Care Philosophy: Dr Michael Jain is an Associate Member and ICE-T Medical Director in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr Jain earned his MD and PhD at McGill University in Montrv©al, in the province of Quv©bec, Canada. His PhD in Cell Biology was completed under the supervision of Dr John Bergeron. Dr Jain completed an Internal Medicine Residency and a Hematology Residency at the University of Toronto. He completed a Clinician Scientist Training Program and Clinical Fellowship in Lymphoma and Autologous Stem Cell Transplantation at Princess Margaret Cancer Center, University of Toronto.

Care Philosophy: Dr Ochoa-Bayona's interests are in traditional bone marrow transplant using high dose chemotherapy and autologous or allogeneic stem transplant to treat myeloma, lymphoma, advanced or recurrent germ cell tumors of the ovary and testis despite standard chemotherapy, myelodysplastic syndromes, acute and chronic leukemias. He completed his training in Internal Medicine, Hematology/Medical Oncology and Hematopoietic Stem Cell Transplantation from the University of Texas Health Science Center at San Antonio in 2002.

Care Philosophy: Dr Bejanyan is an Associate Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida.Dr Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core. As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia.

Care Philosophy: Dr Chan received her MD degree from the University of Arizona College of Medicine, Phoenix. She completed an Internal Medicine Residency at the University of Arizona College of Medicine in Tucson, followed by a Hematology/Oncology Fellowship at Moffitt Cancer Center/University of South Florida. Dr Chan's clinical interests include myeloid malignancies, specifically myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Her research interests include clinical trials and outcome studies inspired by molecular targets that focus on myeloid neoplasms.

Care Philosophy: Over the past fifteen years, Dr Sokol's clinical and laboratory work has been focused on T-cell lymphomas and leukemias and rare lymphoproliferative and histiocytic disorders including Castleman disease, Langerhans Cell Histiocytosis, Hemophagocytic LymphoHistiocytosis, Rosai-Dorfman Disease, etc. He has participated in numerous clinical trials for T cell malignancies including pivotal studies with romidepsin and mogamulizumab. He also led clinical research in T-cell and NK-cell large granular lymphocytic leukemia (LGL). Dr Sokol has been the Co-Director of the Cutaneous Lymphoma Multidisciplinary Clinic for over 15 years. This clinic is the largest referral center for patients with cutaneous T cell lymphoma (CTCL) in the southeastern U.S.

Care Philosophy: Dr. Naraev believes in compassionate, personalized care that is focused on his patients, their hopes, needs and quality of life.

Care Philosophy: Dr Xie is a hematologist and assistant member in the Moffitt Cancer Center Malignant Hematology Department. Dr Xie completed her hematology/oncology fellowship training at the Mayo Clinic, Rochester, MN, Master of Science in Clinical Research and Geriatric fellowship training at the UCLA, Ronald Reagan Medical Center. She focuses on treating myeloid malignancies and precursor stages, including clonal hematopoiesis of indeterminate potential (CHIP), clonal cytopenia (CCUS), MDS, MPN, CMML, and Acute Leukemia. Her research focuses on clinical and translational science, including identifying and preventing cancer at early stage, bridging bench-to-bedside research with designing novel therapeutics and clinical trials.

Care Philosophy: Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.